Table 1 Demographic details of 115 patients with oral squamous cell carcinoma
| Â | Frequency (%) | Â | Frequency (%) |
|---|---|---|---|
Gender | Â | Differentiation | Â |
Male | 65 (56.5) | Well | 32 (27.8) |
Female | 50 (43.5) | Moderate | 60 (52.2) |
| Â | Â | Moderate-poorly | 11 (9.6) |
Race | Â | Poorly | 12 (10.4) |
Caucasian | 78 (67.8) | Â | Â |
Indian | 10 (8.7) | pTNM | Â |
Middle-Eastern | 2 (1.7) | T1N0M0 | 58 (50.4) |
Oriental | 1(0.9) | T2N0M0 | 23 (20.0) |
Other Asians | 6 (5.2) | T1N1M0 | 6 (5.2) |
African | 13 (11.3) | T2N1M0 | 6 (5.2) |
Caribbean | 5 (4.3) | T1N2aM0 | 6 (5.2) |
| Â | Â | T2N2aM0 | 9 (7.8) |
Primary site | Â | T1N2bM0 | 1 (0.9) |
Floor of mouth | 24 (20.9) | T2N2bM0 | 3 (2.6) |
Tongue (lateral) | 36 (31.3) | T1N2cM0 | 2 (1.7) |
Tongue (dorsal) | 13 (11.3) | T2N2cM0 | 1 (0.9) |
Tongue (ventral) | 5 (4.3) | Â | Â |
Buccal mucosa | 11 (9.6) | Invasive front (IF) | Â |
Hard palate | 3 (2.6) | Cohesive | 82 (71.3) |
Upper alveolus | 6 (5.2) | Non-cohesive | 33 (28.7) |
Lower alveolus | 6 (5.2) | Dys. At Margin | 53 (46.1) |
Retromolar area | 3 (2.6) | Lymphvascular Invasion | 28 (24.3) |
Tuberosity | 1 (0.9) | Nerve Invasion | 12 (10.4) |
Upper lip | 1 (0.9) | B/C Invasion | 5 (4.3) |
Lower lip | 5 (4.3) | SD present | 72 (62.6) |
Neck Lump* | 1 (0.9) | Tumour clearance | 107 (93.0) |
cTNM | Â | Recurrence | 43 (37.4) |
T1N0M0 | 62 (53.9) | Â | Â |
T2N0M0 | 24 (20.9) | Recurrence Rx | Â |
T1N1M0 | 3 (2.6) | Surgery | 2 (1.7) |
T2N1M0 | 5 (4.3) | Surgery + radio | 13 (11.3) |
T1N2aM0 | 5 (4.3) | Radio + chemo | 5 (4.3) |
T2N2aM0 | 9 (7.8) | PDT | 2 (1.7) |
T1N2bM0 | 1 (0.9) | Radiotherapy | 21 (18.3) |
T2N2bM0 | 3 (2.6) | Â | Â |
T1N2cM0 | 3 (2.6) | 3 year survival | 86 (74.8) |
Primary Rx | Â | 5 year survival | 83 (72.2) |
Surgery | 90 (78.3) | Â | Â |
Surgery + radio | 22 (19.1) | Â | Â |
Surgery + radio + chemo | 3 (2.6) | Â | Â |
Age at 1st OSCC | Â | Depth of Invasion (mm) | Â |
Minimum | 20 | Minimum | 1.0 |
Maximum | 96 | Maximum | 18.0 |
Mean | 61.70 | Mean | 5.657 |